http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005502603-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
filingDate | 2002-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2005502603-A |
titleOfInvention | Process for producing piperidine derivative fexofenadine |
abstract | The present invention produces certain piperidine derivatives containing the active ingredient fexofenadine (F) (see scheme) in non-sedating antihistamines sold in the United States under the name “Allegra®”. Regarding the method. The invention also relates to novel synthetic intermediates useful in the methods of the invention. |
priorityDate | 2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.